Results 91 to 100 of about 540,225 (295)
Annals of Cardiac Anaesthesia, 2015 Transcatheter valve implantation continues to grow worldwide and has been used principally for the nonsurgical management of native aortic valvular disease-as a potentially less invasive method of valve replacement in high-risk and inoperable patients ...
Harish Ramakrishna +3 more
doaj +1 more source
A Review of “Access to Care” Issues in Aortic Stenosis Patients: A Negative Report Card
Structural HeartThe identification and management of patients with aortic stenosis exist along a continuum that includes healthy living, latent progression, diagnosis, treatment, and posttreatment recovery.
Adam M. Reisman, MD +1 more
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Journal of Cardiovascular Development and Disease(1) Background: Concomitant mild aortic valve disease is frequently found in patients undergoing rheumatic mitral valve surgery. To date, only a limited number of single-center studies have specifically addressed the untreated baseline aortic valve ...
Chong Luo +4 more
doaj +1 more source
Aortic Valve Stenosis in Alkaptonuria [PDF]
The Annals of Thoracic Surgery, 2017 Christos, Tourmousoglou +2 more
openaire +2 more sources
Interventional therapies for chronic heart failure: An overview of recent developments
ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
Low-Gradient, Low Ejection Fraction Severe Aortic Stenosis: Still a Management Conundrum
Cardiovascular Innovations and Applications, 2018 The management of patients with severe symptomatic aortic stenosis and a high transvalvular gradient is straightforward. It requires aortic valve replacement. Management of aortic stenosis patients with low flow, low ejection fraction and low gradient is
Blase A. Carabello
doaj +1 more source
Sutureless valves in aortic stenosis [PDF]
The Journal of Thoracic and Cardiovascular Surgery, 2014 Soppa, Gopal, Jahangiri, Marjan
openaire +2 more sources
ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies +23 more
wiley +1 more source